Integrated Plasma snoRNA–Protein Network Analysis Identifies Circulating Molecular Signatures Associated with High-Risk Benign Breast Lesions and Early Breast Cancer
Open Access
- 25 October 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9530
Abstract
High-risk benign breast lesions increase subsequent breast cancer risk, yet circulating molecular patterns that distinguish them from early breast cancer remain poorly defined. We profiled plasma small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) using UMI-based small RNA sequencing in 32 plasma samples from patients with low-risk benign lesions (Be; 9), high-risk benign lesions (HB; 14), or early breast cancer (CA; 9), and integrated matched data-independent acquisition (DIA) proteomics in a subset of 20 samples (HB; 11, CA; 9). Weighted gene co-expression network analysis (WGCNA) of 475 molecular features identified 11 modules. The Yellow module contained 25 snoRNAs/scaRNAs and 26 proteins and was enriched for extracellular matrix (ECM), blood microparticle, platelet, and serine-type endopeptidase inhibitor functions. An exploratory Yellow-module-focused analysis identified 10 snoRNAs with nominally lower abundance in CA than in HB (p < 0.05), showing concordant directions of differential abundance with the global analysis. The strength of differential RNA evidence correlated with mean intramodular RNA–protein correlation (Spearman ρ = 0.788, p = 2.85 × 10−6). External snoDB target mapping supported 28.6% of the exploratory network edges, including SNORD38A–FN1, SNORA73B–LAMB1, SNORD22–LAMB1, and SNORD22–NCAM1. Integration of differential plasma snoRNA profiling, cross-omic network analysis, and experimentally observed snoRNA interaction data indicated convergence on ECM/collagen and platelet/coagulation biology. These candidate snoRNA–protein axes may characterize differences in the circulating molecular states of CA and HB.Keywords
Funding Information
- University of North Texas Health Science Center at Fort Worth
- National Institutes of Health (1OT2OD032581)
- National Institutes of Health (UE5HG013826)
- National Institutes of Health (U54HG013243)
- National Institutes of Health (T32DK137523)
- National Institutes of Health (R01CA230514)
- National Institutes of Health (P20GM103466)
- National Institutes of Health (U54GM138062)
- National Institutes of Health (U54MD007601)
- National Institutes of Health (P20GM161995)
- Jean Epstein Foundation Medical Research Grant
- Chun Foundation Medical Research Grant
This publication has 56 references indexed in Scilit:
- snoRNA-facilitated protein secretion revealed by transcriptome-wide snoRNA target identificationCell, 2024
- Unfolding the cascade of SERPINA3: Inflammation to cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- The extracellular matrix in tumor progression and metastasisClinical & Experimental Metastasis, 2019
- A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human CancerCell Reports, 2017
- Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle BiopsyJAMA Oncology, 2017
- Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of womenCancer, 2016
- Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasisThe Journal of Pathology, 2016
- Flat epithelial atypia and risk of breast cancer: A Mayo cohort studyCancer, 2015
- Extracellular matrix components in breast cancer progression and metastasisThe Breast, 2013
- The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesionsBreast Cancer Research and Treatment, 2012